Gilead Asia Pacific Rainbow Grant


View website Save this grant
Crystal ball icon
Predicted Deadline
The next cycle for this opportunity is predicted based on past data. If you save this grant, we’ll notify you if there are any changes.

Predicted deadline: Jul 28, 2025

Grant amount: Unspecified amount

Fields of work: HIV/AIDS

Applicant type: Nonprofit

Funding uses: Project / Program, Education / Outreach, Training / Capacity Building

Location of project: Bangladesh; Bhutan; Brunei Darussalam; Cambodia; China Show all

Location of residency: Bangladesh; Bhutan; Brunei Darussalam; Cambodia; China Show all


Ending the HIV epidemic for everyone, everywhere

Our vision at Gilead is to ensure worldwide access to equitable care. This starts with understanding the unique barriers that keep people from meaningful, life-changing care. We are adapting our approach to HIV care to better support people and communities impacted by the disease to fight and end the HIV epidemic.

Founded in the San Francisco Bay area, one of the epicenters of the initial HIV outbreak, we have witnessed first-hand the devastation HIV has and is causing in communities around the world. Over the last 35 years, we have transformed and simplified care for people with HIV. However, the fight to end HIV is far from over.

In Asia Pacific, there are still about 6 million people living with HIV in the region who face social and cultural stigma and punitive laws that prevent them from getting tested, accessing basic healthcare services, progressing socially and economically, or even discussing sexual health openly.

Stigma is insidious, and in order to end HIV as a global health threat, we must eliminate all forms of HIV-related stigma to ensure that all people can safely access the high-quality HIV prevention, care, treatment, and other healthcare services they need.

Gilead is uniquely positioned to accelerate progress towards the Joint United Nations Program’s 95-95-95 goals on HIV by 2025 as we seek to empower underserved communities that experience obstacles to care and help people living with HIV (PLHIV) lead healthy and enriching lives. Since 2018, we are proud to have launched the Gilead Asia Pacific Rainbow Grant (Rainbow Grant), and to date have provided a total of more than $4.5 million in funding support to 84 organizations spanning over 112 projects in this region.

As we mark the fifth anniversary of the Rainbow Grant, this year our focus will be on “Reducing Stigma & Improving Equity”. To improve equitable quality of life for PLHIV, varied responses to tackle stigma and discrimination against HIV must be integrated and people-centric. Together with experts like you, we are reaching across cultures, languages, and communities to make sure we end the HIV epidemic for everyone, everywhere.

Our focus areas

Under the overarching theme of “Reducing Stigma & Improving Equity”, there are three focus areas of projects that we hope to support in 2023.

Focus 1: Addressing HIV-related social determinants of health that impact at-risk populations

Stigma drives discrimination and inequity across sectors of society, including in health care, education, workplace, and justice systems, as well as within families and communities. By deepening our understanding and approaches to addressing intersectional socio-structural factors that impact HIV-related stigma and inequity, we can better understand and attend to the many dimensions, such as strengthening communities, peer-to-peer education and capacity building, harm reduction and HIV prevention, that may contribute to or help ameliorate the impact of HIV stigma on PLHIV and individuals at-risk to greatly improve the health and well-being of the population facing HIV-related stigma.

Focus 2: Integrating mental wellness in HIV care & stigma

Stigma is a social phenomenon known to have a negative impact on the lives of PLHIV, so much so that HIV has been characterized as a traumatic experience for PLHIV. Many experience stigma which can cause negative mental health disorders and experiences, including emotional distress, shame, depression, anxiety and suicidal ideation. The anticipation of prejudice and discrimination creates social anxiety in PLHIV, in turn aggravating negative beliefs, views and feelings of oneself as it relates to an individual's HIV-positive status. A people-centered approach to integrating mental wellness into HIV care can alleviate internalized stigma and enhance coping strategies, improving compliance and adherence to treatment for PLHIV.

Focus 3: Uplifting populations “being left behind”

People who are at risk of contracting HIV comprises a highly diverse and heterogeneous community. This risk may propagate to general populations via so-called bridging groups, depending on the extent and nature of social linkages and networks between these populations. The same HIV-related stigma and inequity that are barriers to better-served key populations are more pronounced for those underserved communities that have less access to comprehensive services or limited health coverage. Examples of those groups include young people, women, migrants, displaced populations and the vulnerable.

*The above-mentioned projects are examples only. Applicants are free to submit a project and project type that’s not listed, as long as it addresses one of three focus areas. 

You can learn more about this opportunity by visiting the funder's website.


  • Nonprofit status: Certification of non-profit tax status through an official or government-issued document is required for all applicants.
  • Must be established for at least two years upon the time of the grant application
  • Have a strong track record of sound financial stewardship and ability to deliver impactful programming
  • Have strong commitment to good corporate governance, compliance, and ethics
  • Demonstrate understanding of HIV and affected communities
  • Have a strong network, partnership capacity, and ability to collaborate effectively
  • Grantees must be in at least one of the following territories: Bangladesh, Bhutan, Brunei, Cambodia, Mainland China, Hong Kong, India, Indonesia, Japan, Laos, Malaysia, Maldives, Myanmar, Nepal, Pakistan, Papua New Guinea, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam. 
  • 2021 grantees are welcome to apply, but disbursement of grants will be subject to the successful completion of the final report of the 2021 grant project. 


  • Gilead funding may not be used to pay for or offset the cost of:
    • Medications or purchase of medications
    • Direct medical expenses, including labs
    • Existing deficits or debts
    • Basic biomedical research, clinical research or clinical trials
    • Projects that directly influence or advance Gilead’s business including purchase, utilization, prescribing, formulary position, pricing, reimbursement, referral, recommendation or payment for products
    • Individuals, individual health care providers or physician group practices
    • Events or programs that have already occurred
    • Government lobbying activities
  • Funding will not be provided to organizations that discriminate on the basis of race, color, gender, religion, disability, sexual orientation, gender identity or expression


Your history with this funder
No saved opportunities from this funder yet
Save this opportunity to add notes...
Save this opportunity to add contacts...

This page was last reviewed June 05, 2023 and last updated June 05, 2023